학술논문
PD-3 Phase 1 trial of vibostolimab plus pembrolizumab for PD-1/PD-L1 inhibitor-naive advanced gastric cancer: The KEYVIBE-001 trial
Document Type
Abstract
Author
Source
In Annals of Oncology June 2022 33 Supplement 4:S240-S240
Subject
Language
ISSN
0923-7534